Stock listing
Frankfurt:2VJ Ascletis Pharma, Inc. Aktie
German listing (Frankfurt) of Ascletis Pharma, Inc. · home listing HKEX:1672
Follow Ascletis Pharma, Inc. into a list and get an email when it puts out news.
Share price · FWB:2VJ
€0.494 EUR +0.010 (+2.1%)
Close on Nov 17, 2026
- Day range
- €0.494 – €0.496 EURNov 17, 2026
- Market cap
- €518.5M EURAt the close on Nov 17, 2026 · price × 1.05B shares outstanding
- 52-week range
- €0.467 – €2.057 EURLowest and highest trades, Nov 18, 2025 – Nov 17, 2026
- Traded on an average day
- €729 EURMedian day 0 shares · 47 days with no trades · last 3 months, Aug 17, 2026 – Nov 6, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| HKEX:1672 · Home | $4.37 HKD | +0.005 (+0.1%) | 585,080 | $4.365 | $4.50 | $4.175 | $4.365 | Close on Nov 18, 2026 |
| OTC:ASCLF | $0.625 USD | -0.095 (-13.2%) | 5,350 | $0.620 | $0.625 | $0.620 | $0.720 | Close on Nov 10, 2026 |
| Frankfurt:2VJ | €0.494 EUR | +0.010 (+2.1%) | — | €0.496 | €0.496 | €0.494 | €0.484 | Close on Nov 17, 2026 |
| Stuttgart:2VJ | €0.494 EUR | +0.012 (+2.5%) | — | €0.494 | €0.494 | €0.492 | €0.482 | Close on Nov 17, 2026 |
Daily closes
Last 3 months, Aug 17, 2026 – Nov 6, 2026 · FWB:2VJ · EUR, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| €0.506 | -0.033 | -6.1% | €0.506 | €0.506 | €0.506 | 0 | |
| €0.539 | +0.034 | +6.7% | €0.539 | €0.545 | €0.535 | 2,000 | |
| €0.505 | +0.032 | +6.8% | €0.509 | €0.513 | €0.502 | 2,000 | |
| €0.473 | -0.042 | -8.2% | €0.478 | €0.478 | €0.467 | 0 | |
| €0.515 | -0.023 | -4.3% | €0.526 | €0.532 | €0.513 | 0 | |
| €0.538 | -0.041 | -7.1% | €0.542 | €0.545 | €0.536 | 0 | |
| €0.579 | -0.026 | -4.3% | €0.579 | €0.582 | €0.576 | 1,200 | |
| €0.605 | +0.004 | +0.7% | €0.608 | €0.608 | €0.604 | 52 | |
| €0.601 | -0.020 | -3.2% | €0.612 | €0.612 | €0.599 | 0 | |
| €0.621 | -0.013 | -2.1% | €0.621 | €0.621 | €0.621 | 0 | |
| €0.634 | +0.025 | +4.1% | €0.629 | €0.638 | €0.627 | 0 | |
| €0.609 | -0.057 | -8.6% | €0.609 | €0.610 | €0.609 | 0 | |
| €0.666 | +0.032 | +5.0% | €0.670 | €0.670 | €0.661 | 0 | |
| €0.634 | -0.017 | -2.6% | €0.654 | €0.654 | €0.630 | 6,000 | |
| €0.651 | +0.001 | +0.2% | €0.652 | €0.652 | €0.642 | 0 | |
| €0.650 | +0.005 | +0.8% | €0.659 | €0.662 | €0.643 | 0 | |
| €0.645 | -0.008 | -1.2% | €0.645 | €0.651 | €0.642 | 0 | |
| €0.653 | -0.087 | -11.8% | €0.660 | €0.665 | €0.652 | 0 | |
| €0.740 | -0.025 | -3.3% | €0.744 | €0.747 | €0.739 | 0 | |
| €0.765 | -0.016 | -2.0% | €0.767 | €0.768 | €0.761 | 0 | |
| €0.781 | -0.062 | -7.4% | €0.785 | €0.787 | €0.781 | 28 | |
| €0.843 | -0.105 | -11.1% | €0.844 | €0.844 | €0.842 | 0 | |
| €0.948 | -0.064 | -6.3% | €0.947 | €0.950 | €0.941 | 0 | |
| €1.012 | +0.095 | +10.4% | €1.012 | €1.024 | €1.001 | 0 | |
| €0.917 | +0.015 | +1.7% | €0.923 | €0.923 | €0.911 | 0 | |
| €0.902 | -0.019 | -2.1% | €0.901 | €0.902 | €0.900 | 0 | |
| €0.921 | -0.008 | -0.9% | €0.916 | €0.923 | €0.916 | 4,000 | |
| €0.929 | +0.006 | +0.7% | €0.930 | €0.930 | €0.918 | 0 | |
| €0.923 | -0.005 | -0.5% | €0.941 | €0.945 | €0.909 | 0 | |
| €0.928 | -0.009 | -1.0% | €0.917 | €0.931 | €0.917 | 0 | |
| €0.937 | -0.029 | -3.0% | €0.937 | €0.943 | €0.933 | 2,000 | |
| €0.966 | -0.043 | -4.3% | €0.966 | €0.966 | €0.966 | 0 | |
| €1.009 | +0.028 | +2.9% | €1.008 | €1.028 | €1.008 | 0 | |
| €0.981 | -0.028 | -2.8% | €0.972 | €0.982 | €0.962 | 0 | |
| €1.009 | +0.040 | +4.1% | €1.010 | €1.010 | €1.004 | 0 | |
| €0.969 | +0.083 | +9.4% | €0.983 | €0.985 | €0.962 | 13,258 | |
| €0.886 | -0.008 | -0.9% | €0.887 | €0.887 | €0.879 | 0 | |
| €0.894 | -0.072 | -7.5% | €0.912 | €0.913 | €0.893 | 0 | |
| €0.966 | -0.004 | -0.4% | €0.957 | €0.972 | €0.930 | 2,728 | |
| €0.970 | -0.080 | -7.6% | €0.971 | €0.971 | €0.970 | 0 | |
| €1.050 | -0.019 | -1.8% | €1.066 | €1.067 | €1.049 | 7,000 | |
| €1.069 | -0.015 | -1.4% | €1.060 | €1.085 | €1.052 | 0 | |
| €1.084 | -0.001 | -0.1% | €1.084 | €1.099 | €1.083 | 0 | |
| €1.085 | -0.034 | -3.0% | €1.101 | €1.106 | €1.082 | 0 | |
| €1.119 | +0.024 | +2.2% | €1.124 | €1.127 | €1.115 | 0 | |
| €1.095 | -0.026 | -2.3% | €1.095 | €1.109 | €1.095 | 4,000 | |
| €1.121 | +0.030 | +2.7% | €1.122 | €1.122 | €1.118 | 0 | |
| €1.091 | +0.051 | +4.9% | €1.081 | €1.101 | €1.079 | 0 | |
| €1.040 | 0.000 | 0.0% | €1.040 | €1.040 | €1.033 | 0 | |
| €1.040 | -0.040 | -3.7% | €1.048 | €1.048 | €1.040 | 0 | |
| €1.080 | -0.034 | -3.1% | €1.068 | €1.091 | €1.065 | 4,000 | |
| €1.114 | +0.059 | +5.6% | €1.105 | €1.128 | €1.100 | 0 | |
| €1.055 | -0.002 | -0.2% | €1.073 | €1.074 | €1.052 | 0 | |
| €1.057 | +0.022 | +2.1% | €1.057 | €1.057 | €1.057 | 0 | |
| €1.035 | -0.038 | -3.5% | €1.037 | €1.037 | €1.023 | 0 | |
| €1.073 | -0.027 | -2.5% | €1.073 | €1.080 | €1.061 | 0 | |
| €1.100 | +0.026 | +2.4% | €1.113 | €1.114 | €1.085 | 0 | |
| €1.074 | -0.018 | -1.6% | €1.074 | €1.074 | €1.074 | 0 | |
| €1.092 | -0.030 | -2.7% | €1.109 | €1.115 | €1.089 | 0 | |
| €1.122 | -0.006 | -0.5% | €1.114 | €1.132 | €1.111 | 0 |
- Ticker
- Frankfurt:2VJ
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- Frankfurt
- Currency
- EUR
What changed lately
Latest news release · Nov 17, 2026
Voluntary announcement - ascletis submits IND application to the U.S. FDA for ASC36_37O FDC, a potentially first-in-class once-weekly oral quadruple peptide agonist targeting amylin receptor, GLP-1R, GIPR and GCGR, for the treatment of obesity
Latest deck · November 2026
Investor Presentation (November 2026)
Investor deck · 23 slides
Latest news
Next Day Disclosure Return
Nov 6, 2026
Closed €0.506 (-6.1%) on Nov 6, 2026
Grant of share options
Nov 4, 2026
Closed €0.505 (+6.8%) on Nov 4, 2026
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2026
Nov 4, 2026
Closed €0.505 (+6.8%) on Nov 4, 2026
Voluntary announcement - ascletis to present study results of oral small molecule GIPR agonist ASC48 and GLP-1R/GIPR/GCGR triple peptide agonist ASC37 at ObesityWeek 2026
Nov 2, 2026
Closed €0.515 (-4.3%) on Nov 2, 2026
Voluntary announcement - ascletis' oral small molecule GLP-1, ASC30, demonstrated placebo-adjusted HBA1C reduction of 1.7% at 12 weeks from its U.S. phase II study in participants with diabetes
Oct 28, 2026
Closed €0.579 (-4.3%) on Oct 29, 2026
Decks
Investor Presentation (November 2026)
Investor deck · 23 slides · November 2026
Investor Presentation (October 2026)
Investor deck · 23 slides · Oct 21, 2026
Investor Presentation (August 2026)
Investor deck · 22 slides · August 2026
EASD 2026
Conference · 8 slides · 2026
Ascletis Pharma, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 57 in the last 12 months · 88 in all · newest Nov 17, 2026 · oldest 2025
- Decks
- 6 decks · latest November 2026
Where Ascletis Pharma, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| HKEX:1672 歌禮製藥 · Home listing | HKEX | Hong Kong | HKD |
| Tradegate:2VJ | Tradegate | Germany | EUR |
| OTC:ASCLF | OTC | United States | USD |
| LS Exchange:A2JRKN | LS Exchange | Germany | EUR |
| gettex:2VJ | gettex | Germany | EUR |
| Lang & Schwarz:A2JRKN | Lang & Schwarz | Germany | EUR |
| Frankfurt:2VJ · This page | Frankfurt | Germany | EUR |
| Dusseldorf:2VJ | Dusseldorf | Germany | EUR |
| Munich:2VJ | Munich | Germany | EUR |
| Stuttgart:2VJ | Stuttgart | Germany | EUR |
Log in to ask 6ix AI your own questions about Ascletis Pharma, Inc.